Patents

Government R&D Tax Credits Consultation

Deadline approaching for the Government R&D Tax Credits Consultation – your input needed for potential changes to RDEC and SME R&D Relief Government R&D Tax Credits Consultation: The UK government intends to raise investment in research and development to 2.4% of UK GDP by 2027 and wants to ensure that one of the key incentives for… Read more »

Careers in Ideas: Virtual work insight days 2021

AA Thornton welcomes five candidates for Virtual work insight days 2021 Earlier this month, we were delighted to welcome five engaging candidates to our first virtual work insight days, including the great-granddaughter of our founding partner Alfred Augustus Thornton.  The two day event was an opportunity for the students to have a practical insight into… Read more »

Antibodies – EPO user consultation on new EPO guidelines

AA Thornton’s Pharma & Biotech experts contribute to the European Patent Office’s peer consultation on the EPOs Guidelines for Examination; Part G chapter II,  section 5.6 concerning Antibodies. On 1st March 2021 the EPO published new guidelines for the examination of claims to antibodies which has raised some some specific concerns regarding the proposed wording… Read more »

G1/19 decision – Patenting Computer Simulation in Europe

G1/19 decision – Patenting Computer Simulation in Europe The much anticipated G1/19 decision has arrived with the EPO Enlarged Board of Appeal confirming that the EPO’s established approach to the assessment of inventive step of computer-implemented inventions is the correct approach for computer-implemented simulation methods. On 10 March 2021, the Enlarged Board issued decision G1/19 and… Read more »

Lack of enablement in Amgen v Sanofi and Regeneron

Amgen v Sanofi and Regeneron: Broad antibody patents held invalid for lack of enablement in US Lack of enablement: A conclusion of lack of enablement means that the disclosure provided in the patent specification, at the time the application was filed, would not have taught one skilled in the art how to make and/or use the full… Read more »

Partner Mike Jennings is reappointed to SACEPO

We are delighted that Partner Mike Jennings has been appointed by the EPO President to continue his contributions to the SACEPO Working Party on Quality for another 3 years. What is SACEPO? The Standing Advisory Committee before the European Patent Office (SACEPO) was formed in 1978. Its aim was to give “interested circles” a say… Read more »

Patenting in the Pandemic

Partner Dr. Lawrence King reflects on Patenting in the Pandemic and the importance of locking down innovation in troubled times in this article, first published in The Chemical Engineer. The importance of locking down innovation in troubled times TO MOST, A Poor Man’s Tale of a Patent, published in October 1850, remains one of Charles Dickens’ lesser-known… Read more »

UKIPO “Green Channel” – can the patent system encourage more innovation in green technologies?

Partners Mike Jennings and Alex Bone explore the UKIPO “Green Channel” At AA Thornton, our patent attorneys have a long history of assisting innovators seeking protection for a variety of green technology including solar technology, waste processing and wind turbines.  Some of our clients were kind enough to share their stories with us, and you… Read more »

AI and IP – A report on CIPA’s Computer Technology Committee recommendations on AI and IP

Whether and when to change UK patent law to increase protection for AI This article follows the recent article ‘Call for industry views on AI and IP and ViCo‘   Introduction In September 2020, the UKIPO launched a “Call for views on AI and IP” (see https://www.gov.uk/government/consultations/artificial-intelligence-and-intellectual-property-call-for-views ), noting the UK government’s desire to understand… Read more »

Categories

Archives